SB 6228 Washington Senate · 2025-2026 Regular Session

Removing a tax exemption for the warehousing and reselling of prescription drugs. (REVISED FOR ENGROSSED: Removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies.)

SB 6228 removes a tax exemption for businesses that warehouse and resell prescription drugs, making this activity subject to a 0.5% tax on gross income under Washington's business tax code (RCW 82.04.280). It directly affects drug wholesalers and retailers registered with the federal DEA and licensed by Washington's Pharmacy Quality Assurance Commission. The bill repeals the existing exemption (RCW 82.04.272) and adds "warehousing and reselling drugs for human use pursuant to a prescription" to the list of taxable activities. The tax change takes effect January 1, 2027, aiming to increase state general fund revenue.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Mar 2026
Senate Passage
Mar 2026
House Passage
Mar 2026
Signed into Law
Apr 2026
Introduced Jan 20, 2026 Signed Apr 1, 2026
Maddy AI version diff · 2 comparisons

What changed between versions

Engrossed Bill Passed Legislature · 5 edits
MODERATE
This bill removes the tax exemption for businesses that warehouse and resell prescription drugs, requiring them to pay a 0.5% tax in 2027 and a 0.35% tax starting in 2028. Simultaneously, it provides significant tax relief to 'critical access pharmacies' by lowering their tax rate to 0.138% to ensure rural and underserved communities maintain affordable drug access. The legislation also updates the legal definition of a critical access pharmacy to include tribal-operated pharmacies and those in high-poverty areas.
Scope change
The bill expands the definition of eligible 'critical access pharmacies' to include tribal-operated facilities and pharmacies in high-poverty census tracts, while removing the tax exemption for drug wholesalers.
FISCAL

Added a new tax on the warehousing and reselling of prescription drugs, set at 0.5% for calendar year 2027 and 0.35% starting January 1, 2028.

Reduced the tax rate for critical access pharmacies from 0.25% to 0.138% to provide tax relief.

ELIGIBILITY

Expanded the definition of 'critical access pharmacy' to include pharmacies operated by tribes and those located in high-poverty census tracts.

DEFINITION

Added a new definition for 'independent pharmacy' to clarify that it excludes large chains, pharmacy benefit managers, and publicly traded entities.

SCOPE

Removed the previous tax exemption for the warehousing and reselling of prescription drugs.

Floor votes · Senate Feb 28, 2026 · House Mar 11, 2026

How they voted

2624
Passed · 1 other
Total votes 51
Feb 28, 2026
D Democratic31
25 Yea 5 Nay 1
80% Yea
R Republican20
1 Yea 19 Nay
95% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
30
Key actions
17
Committee
11
Apr 1, 2026
Signed into law
Governor signed.
executive
Mar 12, 2026
Lower · Passed
Speaker signed.
lower
Mar 12, 2026
Upper · Passed
President signed.
upper
Mar 12, 2026
Upper · Passed
Passed final passage; yeas, 26; nays, 23; absent, 0; excused, 0.
upper
Mar 12, 2026
Upper · Passed
Senate concurred in House amendments.
upper
Mar 11, 2026
Lower · Passed
Committee amendment(s) adopted as amended.
lower
Mar 11, 2026
House · Passed
House Vote: pass (53-43-4)
house
Mar 9, 2026
Committee
Referred to Rules 2 Review.
lower
Mar 7, 2026
Lower · Passed
Minority; do not pass.
lower
Mar 7, 2026
Lower · Passed
FIN - Majority; do pass with amendment(s).
lower
Mar 7, 2026
Lower · Passed
Executive action taken in the House Committee on Finance at 9:00 AM.
lower
Mar 4, 2026
Lower · Passed
Public hearing in the House Committee on Finance at 8:00 AM.
lower
Feb 28, 2026
Upper · Passed
Floor amendment(s) adopted.
upper
Feb 23, 2026
Upper · Passed
Minority; without recommendation.
upper
Feb 23, 2026
Upper · Passed
Minority; do not pass.
upper
Feb 19, 2026
Upper · Passed
WM - Majority; do pass.
upper
Feb 19, 2026
Upper · Passed
Executive action taken in the Senate Committee on Ways & Means at 4:00 PM.
upper
Jan 26, 2026
Upper · Passed
Public hearing in the Senate Committee on Ways & Means at 4:00 PM.
upper
1 primary · 2 co-sponsors

Sponsors